MagneBind 300 and Alcohol/Food Interactions
There is 1 alcohol/food/lifestyle interaction with MagneBind 300 (calcium carbonate / magnesium carbonate).
Calcium Carbonate Food
Moderate Food Interaction
ADJUST DOSING INTERVAL: Administration with food may increase the absorption of calcium. However, foods high in oxalic acid (spinach or rhubarb), or phytic acid (bran and whole grains) may decrease calcium absorption.
MANAGEMENT: Calcium may be administered with food to increase absorption. Consider withholding calcium administration for at least 2 hours before or after consuming foods high in oxalic acid or phytic acid.
References (6)
- Cerner Multum, Inc. "UK Summary of Product Characteristics."
- Canadian Pharmacists Association (2006) e-CPS. http://www.pharmacists.ca/function/Subscriptions/ecps.cfm?link=eCPS_quikLink
- Cerner Multum, Inc. "Australian Product Information."
- Agencia Española de Medicamentos y Productos Sanitarios Healthcare (2008) Centro de información online de medicamentos de la AEMPS - CIMA. https://cima.aemps.es/cima/publico/home.html
- Mangels AR (2014) "Bone nutrients for vegetarians." Am J Clin Nutr, 100, epub
- Davies NT (1979) "Anti-nutrient factors affecting mineral utilization." Proc Nutr Soc, 38, p. 121-8
Switch to consumer interaction data
MagneBind 300 drug interactions
There are 269 drug interactions with MagneBind 300 (calcium carbonate / magnesium carbonate).
MagneBind 300 disease interactions
There are 6 disease interactions with MagneBind 300 (calcium carbonate / magnesium carbonate) which include:
- phosphate calcifications
- cardiac contraction/conduction
- malabsorption
- renal dysfunction
- sarcoidosis
- renal dysfunction
Report options
More about MagneBind 300 (calcium carbonate / magnesium carbonate)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: antacids
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Protonix
Protonix (pantoprazole) is used to treat erosive esophagitis and other conditions involving excess ...
Nexium
Nexium is used to treat GERD and other conditions involving excessive stomach acid. Learn about ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Prilosec
Prilosec (omeprazole) is used to treat symptoms of GERD and other conditions caused by excess ...
Carafate
Carafate is an anti-ulcer medication used to treat active duodenal ulcers. Learn about side ...
Renvela
Renvela (sevelamer) reduces blood levels of phosphorus in people with chronic kidney disease who ...
Ranitidine
Ranitidine is used to treat and prevent ulcers in the stomach and intestines. Includes ranitidine ...
Cimetidine
Cimetidine systemic is used for bronchogenic carcinoma, cutaneous mastocytosis, duodenal ulcer ...
Lansoprazole
Lansoprazole is used to treat stomach and intestinal ulcers, erosive esophagitis and ...
Sucralfate
Sucralfate systemic is used for duodenal ulcer, duodenal ulcer prophylaxis, GERD, hyperphosphatemia ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.